Compounds > (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid
Page last updated: 2024-09-04

(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Epilepsy

(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid has been researched along with Epilepsy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowery, NG; Froestl, W; Getova, D1

Other Studies

1 other study(ies) available for (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Epilepsy

ArticleYear
Effects of GABAB receptor antagonism on the development of pentylenetetrazol-induced kindling in mice.
    Brain research, 1998, Nov-02, Volume: 809, Issue:2

    Topics: Animals; Avoidance Learning; Behavior, Animal; Benzoates; Convulsants; Epilepsy; GABA Antagonists; GABA-B Receptor Antagonists; Kindling, Neurologic; Male; Memory; Mice; Organophosphorus Compounds; Pentylenetetrazole; Phosphinic Acids

1998